Kiniksa Pharmaceuticals (KNSA)

(10% Negative) Kiniksa Pharmaceuticals (KNSA) Announces Delay in million Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment